Management of Chronic Myeloid Leukemia in Advanced Phase

Management of chronic myeloid leukemia (CML) in advanced phases remains a challenge also in the era of tyrosine kinase inhibitors (TKIs) treatment. Cytogenetic clonal evolution and development of resistant mutations represent crucial events that limit the benefit of subsequent therapies in these pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonifacio, Massimiliano, Stagno, Fabio, Scaffidi, Luigi, Krampera, Mauro, Di Raimondo, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823861/
https://www.ncbi.nlm.nih.gov/pubmed/31709190
http://dx.doi.org/10.3389/fonc.2019.01132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823861/
https://www.ncbi.nlm.nih.gov/pubmed/31709190
http://dx.doi.org/10.3389/fonc.2019.01132

Ejemplares similares